NCT02624375View on ClinicalTrials.gov

Immune Response to Shingles Vaccination

PHASE4CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

November 30, 2019

Study Completion Date

November 30, 2019

Conditions
Shingles
Interventions
DRUG

Zoster Vaccine Live

Trial Locations (1)

98104

University of Washington Virology Research Clinic, Seattle

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

University of Washington

OTHER

NCT02624375 - Immune Response to Shingles Vaccination | Biotech Hunter | Biotech Hunter